Literature DB >> 26110208

Percutaneous Removal of Filter-Induced Iliocaval Thrombus Using the AngioVac Device.

Berhane Worku1, Kyle Blake, Iosif Gulkarov, Akhilesh Sista, Arash Salemi.   

Abstract

Most percutaneous mechanical thrombectomy devices entail thrombolysis and/or thrombus fragmentation followed by subsequent aspiration, with the associated risks of bleeding and embolization. We describe the use of the AngioVac system (Angiodynamics, Latham, NY USA) for extraction of extensive iliocaval thrombus associated with an inferior vena cava filter followed by percutaneous inferior vena cava filter extraction in a patient with an absolute contraindication to thrombolysis. The AngioVac may be considered in this scenario as it does not require thrombolytics and can remove whole thrombus, thus overcoming some of the limitations of percutaneous mechanical thrombectomy devices in the setting of subacute and early chronic thrombus.

Entities:  

Mesh:

Year:  2015        PMID: 26110208     DOI: 10.1097/IMI.0000000000000156

Source DB:  PubMed          Journal:  Innovations (Phila)        ISSN: 1556-9845


  3 in total

1.  Efficacy of histotripsy combined with rt-PA in vitro.

Authors:  Kenneth B Bader; Kevin J Haworth; Himanshu Shekhar; Adam D Maxwell; Tao Peng; David D McPherson; Christy K Holland
Journal:  Phys Med Biol       Date:  2016-06-29       Impact factor: 3.609

2.  Use of a Modified Cardiopulmonary Bypass Circuit for Suction Embolectomy with the AngioVac Device.

Authors:  Cara M Michelson; Cornelius M Dyke; Douglas J Wick; Rory Guenther; Dylan Dangerfield; Matthew E Wiisanen
Journal:  J Extra Corpor Technol       Date:  2017-12

3.  En Bloc AngioVac Removal of Thoracic Aortic Mass.

Authors:  Jeanney Kang; Fernando Fleischman; Farhood Saremi; David M Shavelle
Journal:  Tex Heart Inst J       Date:  2020-08-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.